radiopharmacology 

Statements about this table:
the route of administration for both i123 - o - iodohippurate and i123 - mibg (m - iodobenzylguanidine) be iv
i123 - iodide for investigation thyroid uptake have a route of administration of oral or iv , the same as the i123 - iodide for investigation thyroid imaging thyroid metastases imaging
i123 - iodide for thyroid uptake investigation be non - imaging compare to i123 - iodide for thyroid imaging thyroid metastases imaging which be imaging
the route of administration for i123 - iodide be strictly iv
the investigation for thyroid uptake of i123 - iodide be imaging
4 of the investigation be non - imaging and 1 be imaging
the investigation for thyroid uptake be in - vitro
neuroectodermal tumour imaging investigation have a route of administration of oral
name
investigation
route of administration
i123 - iodide
thyroid uptake
oral or iv
i123 - iodide
thyroid imaging thyroid metastases imaging
oral or iv
i123 - o - iodohippurate
renal imaging
iv
i123 - mibg (m - iodobenzylguanidine)
neuroectodermal tumour imaging
iv
i123 - fp - cit
spect imaging of parkinson 's disease
iv
name
in - vitro / in - vivo
imaging / non - imaging
i123 - iodide
in - vivo
non - imaging
i123 - iodide
in - vivo
imaging
i123 - o - iodohippurate
in - vivo
imaging
i123 - mibg (m - iodobenzylguanidine)
in - vivo
imaging
i123 - fp - cit
in - vivo
imaging